US Patent Issued to Fresenius Medical Care Deutschland on March 3 for "Method for temporarily interrupting an extracorporeal blood treatment, control device and blood treatment apparatus" (German Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,666, issued on March 3, was assigned to Fresenius Medical Care Deutschland GmbH (Bad Homburg, Germany).

"Method for temporarily interrupting an extracorporeal blood treatment, control device and blood treatment apparatus" was invented by Uwe Hermann (Nuthetal, Germany), Sabine Kipp (Bad Homburg, Germany), Christine Nachbaur-Sturm (Hofheim a. Ts., Germany), Thomas Pusinelli (Altenstadt, Germany), Martin Gruendken (Rosbach, Germany) and Georg Verch (Wiesbaden, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood ...